IL17A and Arthritis: Pharmacological antagonism of EP4 receptors also attenuated collagen‐induced arthritis progression with concomitant inhibition of the production of IFN‐γ and IL‐17A (Sheibanie et al., 2007a; Chen et al., 2010).